Abstract

Varicella-zoster virus (VZV) causes varicella (chickenpox), becomes latent in ganglia along the entire neuraxis, and may reactivate to cause herpes zoster (shingles). VZV may infect ganglia via retrograde axonal transport from infected skin or through hematogenous spread. Simian varicella virus (SVV) infection of rhesus macaques provides a useful model system to study the pathogenesis of human VZV infection. To dissect the virus and host immune factors during acute SVV infection, we analyzed four SVV-seronegative Chinese rhesus macaques infected intratracheally with cell-associated 5 × 103 plaque-forming units (pfu) of SVV-expressing green fluorescent protein (n = 2) or 5 × 104 pfu of wild-type SVV (n = 2). All monkeys developed viremia and SVV-specific adaptive B- and T-cell immune responses, but none developed skin rash. At necropsy 21 days postinfection, SVV DNA was found in ganglia along the entire neuraxis and in viscera, and SVV RNA was found in ganglia, but not in viscera. The amount of SVV inoculum was associated with the extent of viremia and the immune response to virus. Our findings demonstrate that acute SVV infection of Chinese rhesus macaques leads to ganglionic infection by the hematogenous route and the induction of a virus-specific adaptive memory response in the absence of skin rash.

Highlights

  • Varicella-zoster virus (VZV) is an exclusively human ubiquitous neurotropic alphaherpesvirus

  • Our findings demonstrate that acute Simian varicella virus (SVV) infection of Chinese rhesus macaques leads to ganglionic infection by the hematogenous route and the induction of a virus-specific adaptive memory response in the absence of skin rash

  • The present study showed that after primary infection with SVV, Chinese rhesus macaques developed viremia, ganglionic infection by the hematogenous route and virus-specific memory B- and T-cell responses in the absence of rash

Read more

Summary

Introduction

Varicella-zoster virus (VZV) is an exclusively human ubiquitous neurotropic alphaherpesvirus. Virus is transported from the respiratory mucosa to sites of secondary replication and skin via VZV-infected lymphocytes (Asano et al 1985; Ozaki et al 1994). Virus reaches ganglia either by retrograde axonal transport from infected skin or by hematogenous spread via VZV-infected lymphocytes (Annunziato et al 2000; Reichelt et al 2008). Reactivation of latent VZV results from a decline in virus-specific cellular immunity (Miller 1980), mostly in elderly individuals as well as in immunocompromised organ transplant recipients and HIV+patients, resulting in zoster and multiple other serious neurological and ocular disorders (Gilden et al 2000; Hope-Simpson 1965)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call